Re: Sample Report

Preview text: Hi Friend, Here are the 6 sections of our CEO’s DNA 360 Report report you requested. In…

Wednesday, Oct 14, 2026 at 5:08 PM EasternKlaviyo

Fit to screenFull size

Re: Sample Report - email from The DNA Company

Using this email in an article? Credit: The DNA Company email via They Sent It, with a link to this page. Full-size image

Subject: Re: Sample Report
Preview text: Hi Friend, Here are the 6 sections of our CEO’s DNA 360 Report report you requested. In…
From: clientcare@thednacompany.com
Brand: The DNA Company
ESP: Klaviyo
Sent: Wed Oct 14, 2026, 5:08 PM ET
Sent to: thednacompany.com
Size: 40 KB
Images: 6
Links: 13, 1 of them buttons
Subject length: 17 characters

Against The DNA Company's usual

Sent in the 5 PM hour, which holds 6% of its emails; 18% arrive in the 10 AM hour. The subject is 17 characters; its average is 39.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: The DNA Company <[email protected]>
Subject: Re: Sample Report
Date: Wed, 14 Oct 2026 21:08:08 +0000
Message-ID domain: klaviyomail.com
Return-Path domain: k3.send.thednacompany.com
DKIM signature: d=shared.klaviyomail.com s=def1; d=send.thednacompany.com s=mtd1
List-Unsubscribe: Present, one-click

Servers it passed through, newest first

from (unnamed) by kmta-mta-blue-….servers.clovesoftware.com with SMTP

Other sending headers (names only): X-Mailer-Info-Extra2, X-Mailer-Info, X-Mailer-Info-Extra, X-Kmail-Account, X-Kmail-Flow, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse

Report this email

Sent just before and after

	Oct 19, 2026 4:47 AM	How DNA Impacts Your Immunity
	Oct 16, 2026 4:46 AM	Lose Weight Faster Using DNA Insights
	Oct 15, 2026 4:46 AM	Friend, Claim Your $50 Discount Before it Expires
	Oct 14, 2026 5:08 PM	Re: Sample Report (this email)
	Oct 13, 2026 11:44 PM	Your Free Chapter
	Oct 6, 2026 1:05 PM	Peptides for Hormones, Metabolism & Sexual Health: What’s Real?
	Oct 5, 2026 3:09 PM	Cancer Genetics: A Verdict or a Starting Point?